Department of Medicine (CNB-CSIC) Associated Unit, Laboratory of Immune System Diseases and Oncology, National Biotechnology Center, University of Alcalá, Alcalá de Henares, Madrid, Spain.
Crit Care. 2009;13(1):R26. doi: 10.1186/cc7731. Epub 2009 Feb 25.
Given the pivotal role of T lymphocytes in the immune system, patients with septic shock may show T cell abnormalities. We have characterised the T cell compartment in septic shock and assess its clinical implications.
T lymphocytes from the peripheral blood of 52 patients with septic shock and 36 healthy control subjects were analysed on admission to the intensive care unit, baseline, and 3, 7, 14 and 28 days later. T cell phenotypes (CD3+CD4+/CD3+CD8+, CD45RA+/CD45RO+, CD62L+/CD28+) were assessed by quantitative flow cytometry.
CD3+, CD3+CD4+ and CD3+CD8+ lymphocyte counts were significantly lower in patients with septic shock than control subjects. In surviving patients, CD3+CD4+ lymphocytes had normalised after 14 days, yet CD3+CD8+ numbers were still low. Non effector CD45RA+CD45RO- subsets of CD3+CD4+ and CD3+CD8+ were persistently low during patient follow up. CD3+CD8+CD28+ and CD3+CD8+CD62L+ were reduced in patients versus controls and survivors versus nonsurvivors in the first three days. A prediction receptor operative curve revealed that for the CD3+CD8+CD28+ subset, a cutoff of 136 cells/ml showed 70% sensitivity and 100% specificity for predicting death and the area under the curve was 0.84 at admission. Corresponding values for CD3+CD8+CD62L+ were 141 cells/ml, 60% sensitivity, 100% specificity and an area under the curve of 0.75.
A severe redistribution of T lymphocyte subsets is found in septic shock patients. A different kinetic pattern of T cell subset involvement is observed in surviving and nonsurviving patients, with lower numbers of circulating CD3+CD8+CD28+ and CD3+CD8+CD62L+ associated with a better disease outcome.
鉴于 T 淋巴细胞在免疫系统中的关键作用,败血症性休克患者可能会出现 T 细胞异常。我们已经描述了败血症性休克患者的 T 细胞区室,并评估了其临床意义。
在入住重症监护病房时、基线时以及随后的 3、7、14 和 28 天,分析了 52 例败血症性休克患者和 36 例健康对照者的外周血 T 淋巴细胞。通过定量流式细胞术评估 T 细胞表型(CD3+CD4+/CD3+CD8+、CD45RA+/CD45RO+、CD62L+/CD28+)。
败血症性休克患者的 CD3+、CD3+CD4+和 CD3+CD8+淋巴细胞计数明显低于对照组。在存活患者中,CD3+CD4+淋巴细胞在 14 天后恢复正常,但 CD3+CD8+数量仍较低。在患者随访期间,非效应性 CD45RA+CD45RO-的 CD3+CD4+和 CD3+CD8+亚群持续减少。与对照组相比,患者中 CD3+CD8+CD28+和 CD3+CD8+CD62L+在第 1-3 天减少,与幸存者相比,非幸存者中 CD3+CD8+CD28+和 CD3+CD8+CD62L+减少。预测受体工作曲线显示,对于 CD3+CD8+CD28+亚群,136 个细胞/ml 的截止值可预测死亡率,其敏感性为 70%,特异性为 100%,曲线下面积为 0.84,入院时。CD3+CD8+CD62L+的相应值为 141 个细胞/ml、60%的敏感性、100%的特异性和 0.75 的曲线下面积。
在败血症性休克患者中发现 T 淋巴细胞亚群严重重新分布。在存活和非存活患者中观察到 T 细胞亚群参与的不同动力学模式,循环 CD3+CD8+CD28+和 CD3+CD8+CD62L+数量较低与更好的疾病结局相关。